A

Annovis Bio, Inc.

7 employees

Annovis Bio develops novel treatments for Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders.

Basic info

Industry

biotechnology research

Sectors

Developer Platform

Biotechnology

Neurodegeneration

APP

tau

Traumatic Brain Injury

tau/phospho-tau

neurotoxic proteins

Therapeutics

aSYN

Alzheimer’s in Down Syndrome

APP/Ab (APP)

Parkinson’s

a-Synuclein (a-SYN)

Axonal Transport

Alzheimer’s

Date founded

2008

Funding rounds raised

Total raised

$5.7M

from 7 investors over 7 rounds

A

Annovis Bio, Inc. raised $100K on January 31, 2020

Investors: Robin Hood Ventures

A

Annovis Bio, Inc. raised $800K on October 27, 2016

Investors: Robin Hood Ventures

A

Annovis Bio, Inc. raised $5.7M on May 26, 2015

Investors: Robin Hood Ventures, Delaware Crossing Investor Group and Keiretsu Forum / Capital

A

Annovis Bio, Inc. raised $350K on June 20, 2013

Investors: BioAdvance

A

Annovis Bio, Inc. raised $706K on April 26, 2010